RT Journal Article
SR Electronic
T1 Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 3791
OP 3793
VO 37
IS 7
A1 REMO, MYLENE
A1 ABRAHAM, IVY
A1 KANKANALA, VINEEL
A1 CHACRA, WADIH
A1 DANCIU, OANA C.
YR 2017
UL http://ar.iiarjournals.org/content/37/7/3791.abstract
AB Hepatitis B virus (HBV) reactivation is a known complication of immunosuppressive therapy. While patients who are undergoing treatment with anti-CD20 agents or stem cell transplantation are commonly screened for chronic HBV infection prior to treatment, there are no consensus guidelines regarding HBV screening for patients undergoing chemotherapy for solid tumors. We present a rare case of fulminant liver failure due to HBV reactivation in a patient receiving chemotherapy for breast cancer. Our case highlights the importance of developing definitive guidelines regarding HBV screening in patients receiving chemotherapy for solid tumors and raises the question of the need for universal screening.